Bernstein upgrades American Airlines, 'closer to a have than a have-not'

Investing.com -- Bernstein analysts raised American Airlines (NASDAQ:AAL ) to Outperform from Market-Perform on Tuesday, highlighting a combination of an improved industry backdrop and a new co-branded credit card deal that promises to generate significant cash flow.

The firm also increased its price target for the stock to $24 from $14, reflecting the airline’s improved financial prospects.

“The pricing and revenue environment has continued to improve,” Bernstein wrote, with American Airlines increasing its fourth-quarter 2024 earnings guidance by 73%, now expecting earnings per share in the range of $0.55-$0.75. 

Lower fuel costs and stronger pricing are key drivers of the updated outlook.

The analysts also pointed to American Airlines’ recently announced exclusive co-branded credit card partnership with Citi, which will begin in January 2026. 

The deal is expected to boost annual remuneration from credit card and other partnerships by 10% from 2024 levels, with projected revenue approaching $10 billion. 

According to Bernstein, this could translate into an additional $1.5 billion in pre-tax income compared to 2024.

The new, steady revenue stream is said to address a major critique of the airline: its high leverage. 

Bernstein estimates the terminal value of the credit card deal at approximately $12 billion, which "changes the story for an airline critiqued for its high leverage." 

The analysts believe the deal will enable American Airlines to pay down debt more effectively, significantly improving its financial outlook.

While challenges in corporate and agency revenue recovery are expected to persist through the end of 2025, Bernstein sees the consistent cash flow from the credit card partnership as transformative. 

This development moves Bernstein to believe American Airlines is "closer to a have than a have-not," solidifying its position as a more robust competitor in the airline industry.

Source: Investing.com

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?